<?xml version="1.0" encoding="UTF-8"?>
<GoldLabel drug="SINGULAIR">
  <Text>
    <Section id="S1" name="adverse reactions">  6 ADVERSE REACTIONS

  EXCERPT:   Most common adverse reactions (incidence &gt;=5% and greater than placebo listed in descending order of frequency): upper respiratory infection, fever, headache, pharyngitis, cough, abdominal pain, diarrhea, otitis media, influenza, rhinorrhea, sinusitis, otitis (  6.1  ).

   To report SUSPECTED ADVERSE REACTIONS, contact Merck Sharp &amp; Dohme Corp., a subsidiary of Merck &amp; Co., Inc., at 1-877-888-4231 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.  

 

  6.1 Clinical Trials Experience

  Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice. In the following description of clinical trials experience, adverse reactions are listed regardless of causality assessment.

 The most common adverse reactions (incidence &gt;=5% and greater than placebo; listed in descending order of frequency) in controlled clinical trials were: upper respiratory infection, fever, headache, pharyngitis, cough, abdominal pain, diarrhea, otitis media, influenza, rhinorrhea, sinusitis, otitis.

   Adults and Adolescents 15 Years of Age and Older with Asthma  

 SINGULAIR has been evaluated for safety in approximately 2950 adult and adolescent patients 15 years of age and older in clinical trials. In placebo-controlled clinical trials, the following adverse experiences reported with SINGULAIR occurred in greater than or equal to 1% of patients and at an incidence greater than that in patients treated with placebo:

 Table 1: Adverse Experiences Occurring in &gt;=1% of Patients with an Incidence Greater than that in Patients Treated with Placebo 
                                          SINGULAIR 10 mg/day(%)(n=1955)        Placebo(%)(n=1180)         
  
   Body As A Whole      Pain, abdominal    Asthenia/fatigue    Fever    Trauma           2.91.81.51.0                    2.51.20.90.8            
   Digestive System Disorders      Dyspepsia    Pain, dental    Gastroenteritis, infectious            2.11.71.5                       1.11.00.5              
   Nervous System/Psychiatric      Headache    Dizziness             18.41.9                         18.11.4               
   Respiratory System Disorders      Influenza    Cough    Congestion, nasal            4.22.71.6                       3.92.41.3              
   Skin/Skin Appendages Disorder      Rash               1.6                             1.2                 
   Laboratory Adverse Experiences   [note: Number of patients tested (SINGULAIR and placebo, respectively): ALT and AST, 1935, 1170; pyuria, 1924, 1159.]     ALT increased    AST increased    Pyuria            2.11.61.0                       2.01.20.9              
         The frequency of less common adverse events was comparable between SINGULAIR and placebo.
 

 The safety profile of SINGULAIR, when administered as a single dose for prevention of EIB in adult and adolescent patients 15 years of age and older, was consistent with the safety profile previously described for SINGULAIR.

 Cumulatively, 569 patients were treated with SINGULAIR for at least 6 months, 480 for one year, and 49 for two years in clinical trials. With prolonged treatment, the adverse experience profile did not significantly change.

   Pediatric Patients 6 to 14 Years of Age with Asthma  

 SINGULAIR has been evaluated for safety in 476 pediatric patients 6 to 14 years of age. Cumulatively, 289 pediatric patients were treated with SINGULAIR for at least 6 months, and 241 for one year or longer in clinical trials. The safety profile of SINGULAIR in the 8-week, double-blind, pediatric efficacy trial was generally similar to the adult safety profile. In pediatric patients 6 to 14 years of age receiving SINGULAIR, the following events occurred with a frequency &gt;=2% and more frequently than in pediatric patients who received placebo: pharyngitis, influenza, fever, sinusitis, nausea, diarrhea, dyspepsia, otitis, viral infection, and laryngitis. The frequency of less common adverse events was comparable between SINGULAIR and placebo. With prolonged treatment, the adverse experience profile did not significantly change.

 The safety profile of SINGULAIR, when administered as a single dose for prevention of EIB in pediatric patients 6 years of age and older, was consistent with the safety profile previously described for SINGULAIR.

 In studies evaluating growth rate, the safety profile in these pediatric patients was consistent with the safety profile previously described for SINGULAIR. In a 56-week, double-blind study evaluating growth rate in pediatric patients 6 to 8 years of age receiving SINGULAIR, the following events not previously observed with the use of SINGULAIR in this age group occurred with a frequency &gt;=2% and more frequently than in pediatric patients who received placebo: headache, rhinitis (infective), varicella, gastroenteritis, atopic dermatitis, acute bronchitis, tooth infection, skin infection, and myopia.

   Pediatric Patients 2 to 5 Years of Age with Asthma  

 SINGULAIR has been evaluated for safety in 573 pediatric patients 2 to 5 years of age in single- and multiple-dose studies. Cumulatively, 426 pediatric patients 2 to 5 years of age were treated with SINGULAIR for at least 3 months, 230 for 6 months or longer, and 63 patients for one year or longer in clinical trials. In pediatric patients 2 to 5 years of age receiving SINGULAIR, the following events occurred with a frequency &gt;=2% and more frequently than in pediatric patients who received placebo: fever, cough, abdominal pain, diarrhea, headache, rhinorrhea, sinusitis, otitis, influenza, rash, ear pain, gastroenteritis, eczema, urticaria, varicella, pneumonia, dermatitis, and conjunctivitis.

   Pediatric Patients 6 to 23 Months of Age with Asthma  

 Safety and effectiveness in pediatric patients younger than 12 months of age with asthma have not been established.

 SINGULAIR has been evaluated for safety in 175 pediatric patients 6 to 23 months of age. The safety profile of SINGULAIR in a 6-week, double-blind, placebo-controlled clinical study was generally similar to the safety profile in adults and pediatric patients 2 to 14 years of age. In pediatric patients 6 to 23 months of age receiving SINGULAIR, the following events occurred with a frequency &gt;=2% and more frequently than in pediatric patients who received placebo: upper respiratory infection, wheezing; otitis media; pharyngitis, tonsillitis, cough; and rhinitis. The frequency of less common adverse events was comparable between SINGULAIR and placebo.

   Adults and Adolescents 15 Years of Age and Older with Seasonal Allergic Rhinitis  

 SINGULAIR has been evaluated for safety in 2199 adult and adolescent patients 15 years of age and older in clinical trials. SINGULAIR administered once daily in the morning or in the evening had a safety profile similar to that of placebo. In placebo-controlled clinical trials, the following event was reported with SINGULAIR with a frequency &gt;=1% and at an incidence greater than placebo: upper respiratory infection, 1.9% of patients receiving SINGULAIR vs. 1.5% of patients receiving placebo. In a 4-week, placebo-controlled clinical study, the safety profile was consistent with that observed in 2-week studies. The incidence of somnolence was similar to that of placebo in all studies.

   Pediatric Patients 2 to 14 Years of Age with Seasonal Allergic Rhinitis  

 SINGULAIR has been evaluated in 280 pediatric patients 2 to 14 years of age in a 2-week, multicenter, double-blind, placebo-controlled, parallel-group safety study. SINGULAIR administered once daily in the evening had a safety profile similar to that of placebo. In this study, the following events occurred with a frequency &gt;=2% and at an incidence greater than placebo: headache, otitis media, pharyngitis, and upper respiratory infection.

   Adults and Adolescents 15 Years of Age and Older with Perennial Allergic Rhinitis  

 SINGULAIR has been evaluated for safety in 3357 adult and adolescent patients 15 years of age and older with perennial allergic rhinitis of whom 1632 received SINGULAIR in two, 6-week, clinical studies. SINGULAIR administered once daily had a safety profile consistent with that observed in patients with seasonal allergic rhinitis and similar to that of placebo. In these two studies, the following events were reported with SINGULAIR with a frequency &gt;=1% and at an incidence greater than placebo: sinusitis, upper respiratory infection, sinus headache, cough, epistaxis, and increased ALT. The incidence of somnolence was similar to that of placebo.

   Pediatric Patients 6 Months to 14 Years of Age with Perennial Allergic Rhinitis  

 The safety in patients 2 to 14 years of age with perennial allergic rhinitis is supported by the safety in patients 2 to 14 years of age with seasonal allergic rhinitis. The safety in patients 6 to 23 months of age is supported by data from pharmacokinetic and safety and efficacy studies in asthma in this pediatric population and from adult pharmacokinetic studies.

   6.2 Post-Marketing Experience

  The following adverse reactions have been identified during post-approval use of SINGULAIR. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.

 Blood and lymphatic system disorders: increased bleeding tendency, thrombocytopenia.

 Immune system disorders: hypersensitivity reactions including anaphylaxis, hepatic eosinophilic infiltration.

 Psychiatric disorders: agitation including aggressive behavior or hostility, anxiousness, depression, disorientation, disturbance in attention, dream abnormalities, hallucinations, insomnia, irritability, memory impairment, restlessness, somnambulism, suicidal thinking and behavior (including suicide), tic, and tremor  [see  Warnings and Precautions (5.4)  ]  .

 Nervous system disorders: drowsiness, paraesthesia/hypoesthesia, seizures.

 Cardiac disorders: palpitations.

 Respiratory, thoracic and mediastinal disorders: epistaxis, pulmonary eosinophilia.

 Gastrointestinal disorders: diarrhea, dyspepsia, nausea, pancreatitis, vomiting.

 Hepatobiliary disorders: Cases of cholestatic hepatitis, hepatocellular liver-injury, and mixed-pattern liver injury have been reported in patients treated with SINGULAIR. Most of these occurred in combination with other confounding factors, such as use of other medications, or when SINGULAIR was administered to patients who had underlying potential for liver disease such as alcohol use or other forms of hepatitis.

 Skin and subcutaneous tissue disorders: angioedema, bruising, erythema multiforme, erythema nodosum, pruritus, Stevens-Johnson syndrome/toxic epidermal necrolysis, urticaria.

 Musculoskeletal and connective tissue disorders: arthralgia, myalgia including muscle cramps.

 Renal and urinary disorders: enuresis in children.

 General disorders and administration site conditions: edema.

 Patients with asthma on therapy with SINGULAIR may present with systemic eosinophilia, sometimes presenting with clinical features of vasculitis consistent with Churg-Strauss syndrome, a condition which is often treated with systemic corticosteroid therapy. These events have been sometimes associated with the reduction of oral corticosteroid therapy. Physicians should be alert to eosinophilia, vasculitic rash, worsening pulmonary symptoms, cardiac complications, and/or neuropathy presenting in their patients  [see  Warnings and Precautions (5.5)  ].  

</Section>
    <Section id="S2" name="warnings and precautions">   5 WARNINGS AND PRECAUTIONS

   EXCERPT:    *  Do not prescribe SINGULAIR to treat an acute asthma attack (  5.1  ). 
 *  Advise patients to have appropriate rescue medication available (  5.1  ). 
 *  Inhaled corticosteroid may be reduced gradually. Do not abruptly substitute SINGULAIR for inhaled or oral corticosteroids (  5.2  ). 
 *  Patients with known aspirin sensitivity should continue to avoid aspirin or non-steroidal anti-inflammatory agents while taking SINGULAIR (  5.3  ). 
 *  Neuropsychiatric events have been reported with SINGULAIR. Instruct patients to be alert for neuropsychiatric events. Evaluate the risks and benefits of continuing treatment with SINGULAIR if such events occur (  5.4  and  6.2  ). 
 *  Systemic eosinophilia, sometimes presenting with clinical features of vasculitis consistent with Churg-Strauss syndrome, has been reported. These events have been sometimes associated with the reduction of oral corticosteroid therapy (  5.5  and  6.2  ). 
 *  Inform patients with phenylketonuria that the 4-mg and 5-mg chewable tablets contain phenylalanine (  5.6  ). 
    
 

   5.1 Acute Asthma

  SINGULAIR is not indicated for use in the reversal of bronchospasm in acute asthma attacks, including status asthmaticus. Patients should be advised to have appropriate rescue medication available. Therapy with SINGULAIR can be continued during acute exacerbations of asthma. Patients who have exacerbations of asthma after exercise should have available for rescue a short-acting inhaled beta-agonist.

    5.2 Concomitant Corticosteroid Use

  While the dose of inhaled corticosteroid may be reduced gradually under medical supervision, SINGULAIR should not be abruptly substituted for inhaled or oral corticosteroids.

    5.3 Aspirin Sensitivity

  Patients with known aspirin sensitivity should continue avoidance of aspirin or non-steroidal anti-inflammatory agents while taking SINGULAIR. Although SINGULAIR is effective in improving airway function in asthmatics with documented aspirin sensitivity, it has not been shown to truncate bronchoconstrictor response to aspirin and other non-steroidal anti-inflammatory drugs in aspirin-sensitive asthmatic patients [see  Clinical Studies (14.1)  ]  .

    5.4 Neuropsychiatric Events

   Neuropsychiatric events have been reported in adult, adolescent, and pediatric patients taking SINGULAIR. Post-marketing reports with SINGULAIR use include agitation, aggressive behavior or hostility, anxiousness, depression, disorientation, disturbance in attention, dream abnormalities, hallucinations, insomnia, irritability, memory impairment, restlessness, somnambulism, suicidal thinking and behavior (including suicide), tic, and tremor. The clinical details of some post-marketing reports involving SINGULAIR appear consistent with a drug-induced effect.  

 Patients and prescribers should be alert for neuropsychiatric events. Patients should be instructed to notify their prescriber if these changes occur. Prescribers should carefully evaluate the risks and benefits of continuing treatment with SINGULAIR if such events occur [see  Adverse Reactions (6.2)  ].  

    5.5 Eosinophilic Conditions

  Patients with asthma on therapy with SINGULAIR may present with systemic eosinophilia, sometimes presenting with clinical features of vasculitis consistent with Churg-Strauss syndrome, a condition which is often treated with systemic corticosteroid therapy. These events have been sometimes associated with the reduction of oral corticosteroid therapy. Physicians should be alert to eosinophilia, vasculitic rash, worsening pulmonary symptoms, cardiac complications, and/or neuropathy presenting in their patients. A causal association between SINGULAIR and these underlying conditions has not been established [see  Adverse Reactions (6.2)  ].  

    5.6 Phenylketonuria

  Phenylketonuric patients should be informed that the 4-mg and 5-mg chewable tablets contain phenylalanine (a component of aspartame), 0.674 and 0.842 mg per 4-mg and 5-mg chewable tablet, respectively.

</Section>
  </Text>
  <IgnoredRegions>
    <IgnoredRegion len="19" name="heading" section="S1" start="2" />
    <IgnoredRegion len="26" name="heading" section="S2" start="3" />
    <IgnoredRegion len="468" name="excerpt" section="S1" start="24" />
    <IgnoredRegion len="1074" name="excerpt" section="S2" start="33" />
    <IgnoredRegion len="30" name="heading" section="S1" start="496" />
    <IgnoredRegion len="16" name="heading" section="S2" start="1114" />
    <IgnoredRegion len="34" name="heading" section="S2" start="1542" />
    <IgnoredRegion len="23" name="heading" section="S2" start="1760" />
    <IgnoredRegion len="27" name="heading" section="S2" start="2244" />
    <IgnoredRegion len="27" name="heading" section="S2" start="3156" />
    <IgnoredRegion len="19" name="heading" section="S2" start="3839" />
    <IgnoredRegion len="29" name="heading" section="S1" start="9228" />
  </IgnoredRegions>
  <Mentions>
    <Mention id="M37" len="27" reason="from_drug_use" section="S1" start="1083" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Upper respiratory infection" meddra_llt_id="10046300" meddra_pt="Upper respiratory tract infection" meddra_pt_id="10046306" />
    </Mention>
    <Mention id="M38" len="5" reason="from_drug_use" section="S1" start="1112" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Fever" meddra_llt_id="10016558" meddra_pt="Pyrexia" meddra_pt_id="10037660" />
    </Mention>
    <Mention id="M39" len="8" reason="from_drug_use" section="S1" start="1119" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Headache" meddra_llt_id="10019211" meddra_pt="Headache" meddra_pt_id="10019211" />
    </Mention>
    <Mention id="M40" len="11" reason="from_drug_use" section="S1" start="1129" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Pharyngitis" meddra_llt_id="10034835" meddra_pt="Pharyngitis" meddra_pt_id="10034835" />
    </Mention>
    <Mention id="M41" len="5" reason="from_drug_use" section="S1" start="1142" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Cough" meddra_llt_id="10011224" meddra_pt="Cough" meddra_pt_id="10011224" />
    </Mention>
    <Mention id="M42" len="14" reason="from_drug_use" section="S1" start="1149" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Pain abdominal" meddra_llt_id="10033374" meddra_pt="Abdominal pain" meddra_pt_id="10000081" />
    </Mention>
    <Mention id="M43" len="8" reason="from_drug_use" section="S1" start="1165" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Diarrhea" meddra_llt_id="10012727" meddra_pt="Diarrhoea" meddra_pt_id="10012735" />
    </Mention>
    <Mention id="M44" len="12" reason="from_drug_use" section="S1" start="1175" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Otitis media" meddra_llt_id="10033078" meddra_pt="Otitis media" meddra_pt_id="10033078" />
    </Mention>
    <Mention id="M45" len="9" reason="from_drug_use" section="S1" start="1189" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Influenza" meddra_llt_id="10022000" meddra_pt="Influenza" meddra_pt_id="10022000" />
    </Mention>
    <Mention id="M46" len="10" reason="from_drug_use" section="S1" start="1200" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Rhinorrhea" meddra_llt_id="10039100" meddra_pt="Rhinorrhoea" meddra_pt_id="10039101" />
    </Mention>
    <Mention id="M47" len="9" reason="from_drug_use" section="S1" start="1212" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Sinusitis" meddra_llt_id="10040753" meddra_pt="Sinusitis" meddra_pt_id="10040753" />
    </Mention>
    <Mention id="M48" len="6" reason="from_drug_use" section="S1" start="1223" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Otitis" meddra_llt_id="10033071" meddra_pt="Ear infection" meddra_pt_id="10014011" />
    </Mention>
    <Mention id="M12" len="15" reason="general_term" section="S1" start="1904" type="NonOSE_AE">
      <Normalization meddra_llt="General symptom" meddra_llt_id="10060891" meddra_pt="General symptom" meddra_pt_id="10060891" />
    </Mention>
    <Mention id="M165" len="4,9" reason="from_drug_use" section="S1" start="1925,1931" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Pain abdominal" meddra_llt_id="10033374" meddra_pt="Abdominal pain" meddra_pt_id="10000081" />
    </Mention>
    <Mention id="M49" len="8" reason="from_drug_use" section="S1" start="1944" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Asthenia" meddra_llt_id="10003549" meddra_pt="Asthenia" meddra_pt_id="10003549" />
    </Mention>
    <Mention id="M50" len="7" reason="from_drug_use" section="S1" start="1953" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Fatigue" meddra_llt_id="10016256" meddra_pt="Fatigue" meddra_pt_id="10016256" />
    </Mention>
    <Mention id="M166" len="5" reason="from_drug_use" section="S1" start="1964" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Fever" meddra_llt_id="10016558" meddra_pt="Pyrexia" meddra_pt_id="10037660" />
    </Mention>
    <Mention id="M167" len="6" reason="from_drug_use" section="S1" start="1973" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Trauma" meddra_llt_id="10044461" meddra_pt="Injury" meddra_pt_id="10022116" />
    </Mention>
    <Mention id="M13" len="26" reason="general_term" section="S1" start="2050" type="NonOSE_AE">
      <Normalization meddra_llt="Perinatal disorders of digestive system" meddra_llt_id="10034509" meddra_pt="Gastrointestinal disorder" meddra_pt_id="10017944" />
    </Mention>
    <Mention id="M168" len="9" reason="from_drug_use" section="S1" start="2082" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Dyspepsia-aggravated" meddra_llt_id="10048482" meddra_pt="Dyspepsia" meddra_pt_id="10013946" />
    </Mention>
    <Mention id="M169" len="4,6" reason="from_drug_use" section="S1" start="2095,2101" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Dental discomfort" meddra_llt_id="10054217" meddra_pt="Dental discomfort" meddra_pt_id="10054217" />
    </Mention>
    <Mention id="M170" len="15,10" reason="from_drug_use" section="S1" start="2111,2128" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Gastroenteritis" meddra_llt_id="10017888" meddra_pt="Gastroenteritis" meddra_pt_id="10017888" />
    </Mention>
    <Mention id="M14" len="26" reason="general_term" section="S1" start="2209" type="NonOSE_AE">
      <Normalization meddra_llt="Disorder nervous system" meddra_llt_id="10013242" meddra_pt="Nervous system disorder" meddra_pt_id="10029202" />
      <Normalization meddra_pt="Neurotoxicity" meddra_pt_id="10029350" />
      <Normalization meddra_pt="Neurological symptom" meddra_pt_id="10060860" />
    </Mention>
    <Mention id="M51" len="8" reason="from_drug_use" section="S1" start="2241" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Headache" meddra_llt_id="10019211" meddra_pt="Headache" meddra_pt_id="10019211" />
    </Mention>
    <Mention id="M52" len="9" reason="from_drug_use" section="S1" start="2253" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Dizziness" meddra_llt_id="10013573" meddra_pt="Dizziness" meddra_pt_id="10013573" />
    </Mention>
    <Mention id="M15" len="28" reason="general_term" section="S1" start="2333" type="NonOSE_AE">
      <Normalization meddra_llt="Disorder respiratory system" meddra_llt_id="10013264" meddra_pt="Respiratory disorder" meddra_pt_id="10038683" />
    </Mention>
    <Mention id="M53" len="9" reason="from_drug_use" section="S1" start="2367" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Influenza" meddra_llt_id="10022000" meddra_pt="Influenza" meddra_pt_id="10022000" />
    </Mention>
    <Mention id="M54" len="5" reason="from_drug_use" section="S1" start="2380" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Cough" meddra_llt_id="10011224" meddra_pt="Cough" meddra_pt_id="10011224" />
    </Mention>
    <Mention id="M55" len="10,5" reason="from_drug_use" section="S1" start="2389,2401" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Congestion nasal" meddra_llt_id="10010676" meddra_pt="Nasal congestion" meddra_pt_id="10028735" />
    </Mention>
    <Mention id="M16" len="29" reason="general_term" section="S1" start="2477" type="NonOSE_AE">
      <Normalization meddra_llt="Skin disorder" meddra_llt_id="10040831" meddra_pt="Skin disorder" meddra_pt_id="10040831" />
    </Mention>
    <Mention id="M56" len="4" reason="from_drug_use" section="S1" start="2512" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Rash" meddra_llt_id="10037844" meddra_pt="Rash" meddra_pt_id="10037844" />
    </Mention>
    <Mention id="M17" len="30" reason="general_term" section="S1" start="2587" type="NonOSE_AE">
      <Normalization meddra_llt="Laboratory test abnormal" meddra_llt_id="10023547" meddra_pt="Laboratory test abnormal" meddra_pt_id="10023547" />
    </Mention>
    <Mention id="M57" len="6" reason="from_drug_use" section="S1" start="2717" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Pyuria" meddra_llt_id="10037686" meddra_pt="Pyuria" meddra_pt_id="10037686" />
    </Mention>
    <Mention id="M58" len="13" reason="from_drug_use" section="S1" start="2742" type="OSE_Labeled_AE">
      <Normalization meddra_llt="ALT increased" meddra_llt_id="10001845" meddra_pt="Alanine aminotransferase increased" meddra_pt_id="10001551" />
    </Mention>
    <Mention id="M59" len="13" reason="from_drug_use" section="S1" start="2759" type="OSE_Labeled_AE">
      <Normalization meddra_llt="AST increased" meddra_llt_id="10003544" meddra_pt="Aspartate aminotransferase increased" meddra_pt_id="10003481" />
    </Mention>
    <Mention id="M60" len="6" reason="from_drug_use" section="S1" start="2776" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Pyuria" meddra_llt_id="10037686" meddra_pt="Pyuria" meddra_pt_id="10037686" />
    </Mention>
    <Mention id="M1" len="3" reason="indication" section="S1" start="3039" type="Not_AE_Candidate">
      <Normalization meddra_llt="Bronchospasm" meddra_llt_id="10006482" meddra_pt="Bronchospasm" meddra_pt_id="10006482" />
    </Mention>
    <Mention id="M61" len="11" reason="from_drug_use" section="S1" start="4013" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Pharyngitis" meddra_llt_id="10034835" meddra_pt="Pharyngitis" meddra_pt_id="10034835" />
    </Mention>
    <Mention id="M62" len="9" reason="from_drug_use" section="S1" start="4026" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Influenza" meddra_llt_id="10022000" meddra_pt="Influenza" meddra_pt_id="10022000" />
    </Mention>
    <Mention id="M63" len="5" reason="from_drug_use" section="S1" start="4037" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Fever" meddra_llt_id="10016558" meddra_pt="Pyrexia" meddra_pt_id="10037660" />
    </Mention>
    <Mention id="M64" len="9" reason="from_drug_use" section="S1" start="4044" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Sinusitis" meddra_llt_id="10040753" meddra_pt="Sinusitis" meddra_pt_id="10040753" />
    </Mention>
    <Mention id="M65" len="6" reason="from_drug_use" section="S1" start="4055" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Nausea" meddra_llt_id="10028813" meddra_pt="Nausea" meddra_pt_id="10028813" />
    </Mention>
    <Mention id="M66" len="8" reason="from_drug_use" section="S1" start="4063" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Diarrhea" meddra_llt_id="10012727" meddra_pt="Diarrhoea" meddra_pt_id="10012735" />
    </Mention>
    <Mention id="M67" len="9" reason="from_drug_use" section="S1" start="4073" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Dyspepsia-aggravated" meddra_llt_id="10048482" meddra_pt="Dyspepsia" meddra_pt_id="10013946" />
    </Mention>
    <Mention id="M68" len="6" reason="from_drug_use" section="S1" start="4084" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Otitis" meddra_llt_id="10033071" meddra_pt="Ear infection" meddra_pt_id="10014011" />
    </Mention>
    <Mention id="M69" len="15" reason="from_drug_use" section="S1" start="4092" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Infection viral" meddra_llt_id="10021876" meddra_pt="Viral infection" meddra_pt_id="10047461" />
      <Normalization meddra_pt="Infection reactivation" meddra_pt_id="10070891" />
    </Mention>
    <Mention id="M70" len="10" reason="from_drug_use" section="S1" start="4113" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Laryngitis" meddra_llt_id="10023874" meddra_pt="Laryngitis" meddra_pt_id="10023874" />
    </Mention>
    <Mention id="M2" len="3" reason="indication" section="S1" start="4390" type="Not_AE_Candidate">
      <Normalization meddra_llt="Bronchospasm" meddra_llt_id="10006482" meddra_pt="Bronchospasm" meddra_pt_id="10006482" />
    </Mention>
    <Mention id="M71" len="8" reason="from_drug_use" section="S1" start="4984" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Headache" meddra_llt_id="10019211" meddra_pt="Headache" meddra_pt_id="10019211" />
    </Mention>
    <Mention id="M72" len="19" reason="from_drug_use" section="S1" start="4994" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Infective rhinitis" meddra_llt_id="10021921" meddra_pt="Rhinitis" meddra_pt_id="10039083" />
    </Mention>
    <Mention id="M73" len="9" reason="from_drug_use" section="S1" start="5016" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Varicella" meddra_llt_id="10046980" meddra_pt="Varicella" meddra_pt_id="10046980" />
    </Mention>
    <Mention id="M74" len="15" reason="from_drug_use" section="S1" start="5027" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Gastroenteritis" meddra_llt_id="10017888" meddra_pt="Gastroenteritis" meddra_pt_id="10017888" />
    </Mention>
    <Mention id="M75" len="17" reason="from_drug_use" section="S1" start="5044" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Atopic dermatitis" meddra_llt_id="10003639" meddra_pt="Dermatitis atopic" meddra_pt_id="10012438" />
    </Mention>
    <Mention id="M76" len="16" reason="from_drug_use" section="S1" start="5063" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Acute bronchitis" meddra_llt_id="10000687" meddra_pt="Bronchitis" meddra_pt_id="10006451" />
    </Mention>
    <Mention id="M77" len="15" reason="from_drug_use" section="S1" start="5081" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Tooth infection" meddra_llt_id="10048762" meddra_pt="Tooth infection" meddra_pt_id="10048762" />
    </Mention>
    <Mention id="M78" len="14" reason="from_drug_use" section="S1" start="5098" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Skin infection" meddra_llt_id="10040872" meddra_pt="Skin infection" meddra_pt_id="10040872" />
    </Mention>
    <Mention id="M79" len="6" reason="from_drug_use" section="S1" start="5118" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Myopia" meddra_llt_id="10028651" meddra_pt="Myopia" meddra_pt_id="10028651" />
    </Mention>
    <Mention id="M80" len="5" reason="from_drug_use" section="S1" start="5688" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Fever" meddra_llt_id="10016558" meddra_pt="Pyrexia" meddra_pt_id="10037660" />
    </Mention>
    <Mention id="M81" len="5" reason="from_drug_use" section="S1" start="5695" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Cough" meddra_llt_id="10011224" meddra_pt="Cough" meddra_pt_id="10011224" />
    </Mention>
    <Mention id="M82" len="14" reason="from_drug_use" section="S1" start="5702" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Pain abdominal" meddra_llt_id="10033374" meddra_pt="Abdominal pain" meddra_pt_id="10000081" />
    </Mention>
    <Mention id="M83" len="8" reason="from_drug_use" section="S1" start="5718" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Diarrhea" meddra_llt_id="10012727" meddra_pt="Diarrhoea" meddra_pt_id="10012735" />
    </Mention>
    <Mention id="M84" len="8" reason="from_drug_use" section="S1" start="5728" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Headache" meddra_llt_id="10019211" meddra_pt="Headache" meddra_pt_id="10019211" />
    </Mention>
    <Mention id="M85" len="10" reason="from_drug_use" section="S1" start="5738" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Rhinorrhea" meddra_llt_id="10039100" meddra_pt="Rhinorrhoea" meddra_pt_id="10039101" />
    </Mention>
    <Mention id="M86" len="9" reason="from_drug_use" section="S1" start="5750" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Sinusitis" meddra_llt_id="10040753" meddra_pt="Sinusitis" meddra_pt_id="10040753" />
    </Mention>
    <Mention id="M87" len="6" reason="from_drug_use" section="S1" start="5761" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Otitis" meddra_llt_id="10033071" meddra_pt="Ear infection" meddra_pt_id="10014011" />
    </Mention>
    <Mention id="M88" len="9" reason="from_drug_use" section="S1" start="5769" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Influenza" meddra_llt_id="10022000" meddra_pt="Influenza" meddra_pt_id="10022000" />
    </Mention>
    <Mention id="M89" len="4" reason="from_drug_use" section="S1" start="5780" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Rash" meddra_llt_id="10037844" meddra_pt="Rash" meddra_pt_id="10037844" />
    </Mention>
    <Mention id="M90" len="8" reason="from_drug_use" section="S1" start="5786" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Pain ear" meddra_llt_id="10033393" meddra_pt="Ear pain" meddra_pt_id="10014020" />
    </Mention>
    <Mention id="M91" len="15" reason="from_drug_use" section="S1" start="5796" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Gastroenteritis" meddra_llt_id="10017888" meddra_pt="Gastroenteritis" meddra_pt_id="10017888" />
    </Mention>
    <Mention id="M92" len="6" reason="from_drug_use" section="S1" start="5813" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Eczema" meddra_llt_id="10014184" meddra_pt="Eczema" meddra_pt_id="10014184" />
    </Mention>
    <Mention id="M93" len="9" reason="from_drug_use" section="S1" start="5821" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Urticaria" meddra_llt_id="10046735" meddra_pt="Urticaria" meddra_pt_id="10046735" />
    </Mention>
    <Mention id="M94" len="9" reason="from_drug_use" section="S1" start="5832" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Varicella" meddra_llt_id="10046980" meddra_pt="Varicella" meddra_pt_id="10046980" />
    </Mention>
    <Mention id="M95" len="9" reason="from_drug_use" section="S1" start="5843" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Pneumonia" meddra_llt_id="10035664" meddra_pt="Pneumonia" meddra_pt_id="10035664" />
    </Mention>
    <Mention id="M96" len="10" reason="from_drug_use" section="S1" start="5854" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Dermatitis" meddra_llt_id="10012431" meddra_pt="Dermatitis" meddra_pt_id="10012431" />
    </Mention>
    <Mention id="M97" len="14" reason="from_drug_use" section="S1" start="5870" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Conjunctivitis" meddra_llt_id="10010741" meddra_pt="Conjunctivitis" meddra_pt_id="10010741" />
    </Mention>
    <Mention id="M7" len="6" reason="preexisting_condition_or_risk_factor" section="S1" start="6029" type="Not_AE_Candidate">
      <Normalization meddra_llt="Asthma" meddra_llt_id="10003553" meddra_pt="Asthma" meddra_pt_id="10003553" />
    </Mention>
    <Mention id="M98" len="27" reason="from_drug_use" section="S1" start="6532" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Upper respiratory infection" meddra_llt_id="10046300" meddra_pt="Upper respiratory tract infection" meddra_pt_id="10046306" />
    </Mention>
    <Mention id="M99" len="8" reason="from_drug_use" section="S1" start="6561" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Wheezing" meddra_llt_id="10047924" meddra_pt="Wheezing" meddra_pt_id="10047924" />
    </Mention>
    <Mention id="M100" len="12" reason="from_drug_use" section="S1" start="6571" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Otitis media" meddra_llt_id="10033078" meddra_pt="Otitis media" meddra_pt_id="10033078" />
    </Mention>
    <Mention id="M101" len="11" reason="from_drug_use" section="S1" start="6585" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Pharyngitis" meddra_llt_id="10034835" meddra_pt="Pharyngitis" meddra_pt_id="10034835" />
    </Mention>
    <Mention id="M102" len="11" reason="from_drug_use" section="S1" start="6598" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Tonsillitis" meddra_llt_id="10044008" meddra_pt="Tonsillitis" meddra_pt_id="10044008" />
    </Mention>
    <Mention id="M103" len="5" reason="from_drug_use" section="S1" start="6611" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Cough" meddra_llt_id="10011224" meddra_pt="Cough" meddra_pt_id="10011224" />
    </Mention>
    <Mention id="M104" len="8" reason="from_drug_use" section="S1" start="6622" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Rhinitis" meddra_llt_id="10039083" meddra_pt="Rhinitis" meddra_pt_id="10039083" />
    </Mention>
    <Mention id="M105" len="27" reason="from_drug_use" section="S1" start="7202" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Upper respiratory infection" meddra_llt_id="10046300" meddra_pt="Upper respiratory tract infection" meddra_pt_id="10046306" />
    </Mention>
    <Mention id="M18" len="10" reason="AE_rate_lteq_placebo" section="S1" start="7445" type="NonOSE_AE">
      <Normalization meddra_llt="Somnolence" meddra_llt_id="10041349" meddra_pt="Somnolence" meddra_pt_id="10041349" />
    </Mention>
    <Mention id="M106" len="8" reason="from_drug_use" section="S1" start="7955" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Headache" meddra_llt_id="10019211" meddra_pt="Headache" meddra_pt_id="10019211" />
    </Mention>
    <Mention id="M107" len="12" reason="from_drug_use" section="S1" start="7965" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Otitis media" meddra_llt_id="10033078" meddra_pt="Otitis media" meddra_pt_id="10033078" />
    </Mention>
    <Mention id="M108" len="11" reason="from_drug_use" section="S1" start="7979" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Pharyngitis" meddra_llt_id="10034835" meddra_pt="Pharyngitis" meddra_pt_id="10034835" />
    </Mention>
    <Mention id="M109" len="27" reason="from_drug_use" section="S1" start="7996" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Upper respiratory infection" meddra_llt_id="10046300" meddra_pt="Upper respiratory tract infection" meddra_pt_id="10046306" />
    </Mention>
    <Mention id="M8" len="27" reason="indication" section="S1" start="8224" type="Not_AE_Candidate">
      <Normalization meddra_llt="Perennial allergic rhinitis" meddra_llt_id="10034382" meddra_pt="Rhinitis perennial" meddra_pt_id="10039094" />
    </Mention>
    <Mention id="M9" len="26" reason="indication" section="S1" start="8420" type="Not_AE_Candidate">
      <Normalization meddra_llt="Seasonal allergic rhinitis" meddra_llt_id="10039776" meddra_pt="Seasonal allergy" meddra_pt_id="10048908" />
    </Mention>
    <Mention id="M110" len="9" reason="from_drug_use" section="S1" start="8615" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Sinusitis" meddra_llt_id="10040753" meddra_pt="Sinusitis" meddra_pt_id="10040753" />
    </Mention>
    <Mention id="M111" len="27" reason="from_drug_use" section="S1" start="8626" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Upper respiratory infection" meddra_llt_id="10046300" meddra_pt="Upper respiratory tract infection" meddra_pt_id="10046306" />
    </Mention>
    <Mention id="M112" len="14" reason="from_drug_use" section="S1" start="8655" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Headache sinus" meddra_llt_id="10019224" meddra_pt="Sinus headache" meddra_pt_id="10040744" />
    </Mention>
    <Mention id="M113" len="5" reason="from_drug_use" section="S1" start="8671" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Cough" meddra_llt_id="10011224" meddra_pt="Cough" meddra_pt_id="10011224" />
    </Mention>
    <Mention id="M114" len="9" reason="from_drug_use" section="S1" start="8678" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Epistaxis" meddra_llt_id="10015090" meddra_pt="Epistaxis" meddra_pt_id="10015090" />
    </Mention>
    <Mention id="M115" len="13" reason="from_drug_use" section="S1" start="8693" type="OSE_Labeled_AE">
      <Normalization meddra_llt="ALT increased" meddra_llt_id="10001845" meddra_pt="Alanine aminotransferase increased" meddra_pt_id="10001551" />
    </Mention>
    <Mention id="M19" len="10" reason="AE_rate_lteq_placebo" section="S1" start="8725" type="NonOSE_AE">
      <Normalization meddra_llt="Somnolence" meddra_llt_id="10041349" meddra_pt="Somnolence" meddra_pt_id="10041349" />
    </Mention>
    <Mention id="M10" len="27" reason="indication" section="S1" start="8905" type="Not_AE_Candidate">
      <Normalization meddra_llt="Perennial allergic rhinitis" meddra_llt_id="10034382" meddra_pt="Rhinitis perennial" meddra_pt_id="10039094" />
    </Mention>
    <Mention id="M11" len="26" reason="indication" section="S1" start="8998" type="Not_AE_Candidate">
      <Normalization meddra_llt="Seasonal allergic rhinitis" meddra_llt_id="10039776" meddra_pt="Seasonal allergy" meddra_pt_id="10048908" />
    </Mention>
    <Mention id="M3" len="6" reason="indication" section="S1" start="9148" type="Not_AE_Candidate">
      <Normalization meddra_llt="Asthma" meddra_llt_id="10003553" meddra_pt="Asthma" meddra_pt_id="10003553" />
    </Mention>
    <Mention id="M20" len="36" reason="general_term" section="S1" start="9557" type="NonOSE_AE">
      <Normalization meddra_llt="Blood disorder" meddra_llt_id="10061590" meddra_pt="Blood disorder" meddra_pt_id="10061590" />
      <Normalization meddra_pt="Haematology test abnormal" meddra_pt_id="10057755" />
    </Mention>
    <Mention id="M116" len="27" reason="from_drug_use" section="S1" start="9595" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Bleeding tendency" meddra_llt_id="10005134" meddra_pt="Haemorrhagic diathesis" meddra_pt_id="10062713" />
    </Mention>
    <Mention id="M117" len="16" reason="from_drug_use" section="S1" start="9624" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Thrombocytopenia" meddra_llt_id="10043554" meddra_pt="Thrombocytopenia" meddra_pt_id="10043554" />
    </Mention>
    <Mention id="M21" len="23" reason="general_term" section="S1" start="9644" type="NonOSE_AE">
      <Normalization meddra_llt="Immune system disorder" meddra_llt_id="10021425" meddra_pt="Immune system disorder" meddra_pt_id="10021425" />
    </Mention>
    <Mention id="M118" len="26" reason="from_drug_use" section="S1" start="9669" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Drug hypersensitivity" meddra_llt_id="10013700" meddra_pt="Drug hypersensitivity" meddra_pt_id="10013700" />
      <Normalization meddra_pt="Hypersensitivity" meddra_pt_id="10020751" />
    </Mention>
    <Mention id="M119" len="11" reason="from_drug_use" section="S1" start="9706" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Anaphylaxis" meddra_llt_id="10002218" meddra_pt="Anaphylactic reaction" meddra_pt_id="10002198" />
    </Mention>
    <Mention id="M120" len="33" reason="from_drug_use" section="S1" start="9719" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Hepatic infiltration eosinophilic" meddra_llt_id="10064668" meddra_pt="Hepatic infiltration eosinophilic" meddra_pt_id="10064668" />
    </Mention>
    <Mention id="M22" len="21" reason="general_term" section="S1" start="9756" type="NonOSE_AE">
      <Normalization meddra_llt="Psychiatric disorder NOS" meddra_llt_id="10037174" meddra_pt="Mental disorder" meddra_pt_id="10061284" />
      <Normalization meddra_pt="Psychiatric symptom" meddra_pt_id="10061472" />
    </Mention>
    <Mention id="M121" len="9" reason="from_drug_use" section="S1" start="9779" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Agitation" meddra_llt_id="10001497" meddra_pt="Agitation" meddra_pt_id="10001497" />
    </Mention>
    <Mention id="M122" len="19" reason="from_drug_use" section="S1" start="9799" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Aggressive behavior" meddra_llt_id="10062375" meddra_pt="Aggression" meddra_pt_id="10001488" />
    </Mention>
    <Mention id="M123" len="9" reason="from_drug_use" section="S1" start="9822" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Hostility" meddra_llt_id="10020400" meddra_pt="Hostility" meddra_pt_id="10020400" />
    </Mention>
    <Mention id="M124" len="11" reason="from_drug_use" section="S1" start="9833" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Feeling anxious" meddra_llt_id="10016323" meddra_pt="Anxiety" meddra_pt_id="10002855" />
    </Mention>
    <Mention id="M125" len="10" reason="from_drug_use" section="S1" start="9846" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Anxiety/depression" meddra_llt_id="10002872" meddra_pt="Depression" meddra_pt_id="10012378" />
    </Mention>
    <Mention id="M126" len="14" reason="from_drug_use" section="S1" start="9858" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Disorientation" meddra_llt_id="10013395" meddra_pt="Disorientation" meddra_pt_id="10013395" />
    </Mention>
    <Mention id="M127" len="24" reason="from_drug_use" section="S1" start="9874" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Disturbance in attention" meddra_llt_id="10013496" meddra_pt="Disturbance in attention" meddra_pt_id="10013496" />
    </Mention>
    <Mention id="M128" len="19" reason="from_drug_use" section="S1" start="9900" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Dream delirium" meddra_llt_id="10013628" meddra_pt="Abnormal dreams" meddra_pt_id="10000125" />
    </Mention>
    <Mention id="M129" len="14" reason="from_drug_use" section="S1" start="9921" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Hallucinations" meddra_llt_id="10019077" meddra_pt="Hallucination" meddra_pt_id="10019063" />
    </Mention>
    <Mention id="M130" len="8" reason="from_drug_use" section="S1" start="9937" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Insomnia" meddra_llt_id="10022437" meddra_pt="Insomnia" meddra_pt_id="10022437" />
    </Mention>
    <Mention id="M131" len="12" reason="from_drug_use" section="S1" start="9947" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Irritability" meddra_llt_id="10022998" meddra_pt="Irritability" meddra_pt_id="10022998" />
    </Mention>
    <Mention id="M132" len="17" reason="from_drug_use" section="S1" start="9961" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Memory impairment" meddra_llt_id="10027175" meddra_pt="Memory impairment" meddra_pt_id="10027175" />
    </Mention>
    <Mention id="M133" len="12" reason="from_drug_use" section="S1" start="9980" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Restlessness" meddra_llt_id="10038743" meddra_pt="Restlessness" meddra_pt_id="10038743" />
    </Mention>
    <Mention id="M134" len="12" reason="from_drug_use" section="S1" start="9994" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Somnambulism" meddra_llt_id="10041347" meddra_pt="Somnambulism" meddra_pt_id="10041347" />
    </Mention>
    <Mention id="M135" len="8,8" reason="from_drug_use" section="S1" start="10008,10030" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Suicidal behavior" meddra_llt_id="10065607" meddra_pt="Suicidal behaviour" meddra_pt_id="10065604" />
    </Mention>
    <Mention id="M171" len="17" reason="from_drug_use" section="S1" start="10008" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Suicidal ideation" meddra_llt_id="10042458" meddra_pt="Suicidal ideation" meddra_pt_id="10042458" />
    </Mention>
    <Mention id="M136" len="7" reason="from_drug_use" section="S1" start="10050" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Suicide" meddra_llt_id="10042462" meddra_pt="Completed suicide" meddra_pt_id="10010144" />
    </Mention>
    <Mention id="M137" len="3" reason="from_drug_use" section="S1" start="10060" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Tic" meddra_llt_id="10043833" meddra_pt="Tic" meddra_pt_id="10043833" />
    </Mention>
    <Mention id="M138" len="6" reason="from_drug_use" section="S1" start="10069" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Tremor" meddra_llt_id="10044565" meddra_pt="Tremor" meddra_pt_id="10044565" />
    </Mention>
    <Mention id="M23" len="24" reason="general_term" section="S1" start="10122" type="NonOSE_AE">
      <Normalization meddra_llt="Nervous system disorder" meddra_llt_id="10029202" meddra_pt="Nervous system disorder" meddra_pt_id="10029202" />
      <Normalization meddra_pt="Neurotoxicity" meddra_pt_id="10029350" />
      <Normalization meddra_pt="Neurological symptom" meddra_pt_id="10060860" />
    </Mention>
    <Mention id="M139" len="10" reason="from_drug_use" section="S1" start="10148" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Drowsiness" meddra_llt_id="10013649" meddra_pt="Somnolence" meddra_pt_id="10041349" />
    </Mention>
    <Mention id="M172" len="12" reason="from_drug_use" section="S1" start="10160" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Paraesthesia" meddra_llt_id="10033775" meddra_pt="Paraesthesia" meddra_pt_id="10033775" />
    </Mention>
    <Mention id="M173" len="12" reason="from_drug_use" section="S1" start="10173" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Hypoesthesia" meddra_llt_id="10020976" meddra_pt="Hypoaesthesia" meddra_pt_id="10020937" />
    </Mention>
    <Mention id="M140" len="8" reason="from_drug_use" section="S1" start="10187" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Seizures" meddra_llt_id="10039910" meddra_pt="Seizure" meddra_pt_id="10039906" />
    </Mention>
    <Mention id="M24" len="17" reason="general_term" section="S1" start="10199" type="NonOSE_AE">
      <Normalization meddra_llt="Cardiac disorder" meddra_llt_id="10061024" meddra_pt="Cardiac disorder" meddra_pt_id="10061024" />
    </Mention>
    <Mention id="M141" len="12" reason="from_drug_use" section="S1" start="10218" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Palpitation" meddra_llt_id="10033556" meddra_pt="Palpitations" meddra_pt_id="10033557" />
    </Mention>
    <Mention id="M25" len="47" reason="general_term" section="S1" start="10234" type="NonOSE_AE">
      <Normalization meddra_llt="Respiratory disorder" meddra_llt_id="10038683" meddra_pt="Respiratory disorder" meddra_pt_id="10038683" />
    </Mention>
    <Mention id="M142" len="9" reason="from_drug_use" section="S1" start="10283" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Epistaxis" meddra_llt_id="10015090" meddra_pt="Epistaxis" meddra_pt_id="10015090" />
    </Mention>
    <Mention id="M143" len="22" reason="from_drug_use" section="S1" start="10294" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Pulmonary eosinophilia" meddra_llt_id="10037382" meddra_pt="Pulmonary eosinophilia" meddra_pt_id="10037382" />
    </Mention>
    <Mention id="M26" len="26" reason="general_term" section="S1" start="10320" type="NonOSE_AE">
      <Normalization meddra_llt="Disorder gastrointestinal" meddra_llt_id="10013225" meddra_pt="Gastrointestinal disorder" meddra_pt_id="10017944" />
    </Mention>
    <Mention id="M144" len="8" reason="from_drug_use" section="S1" start="10348" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Diarrhea" meddra_llt_id="10012727" meddra_pt="Diarrhoea" meddra_pt_id="10012735" />
    </Mention>
    <Mention id="M145" len="9" reason="from_drug_use" section="S1" start="10358" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Dyspepsia-aggravated" meddra_llt_id="10048482" meddra_pt="Dyspepsia" meddra_pt_id="10013946" />
    </Mention>
    <Mention id="M146" len="6" reason="from_drug_use" section="S1" start="10369" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Nausea" meddra_llt_id="10028813" meddra_pt="Nausea" meddra_pt_id="10028813" />
    </Mention>
    <Mention id="M147" len="12" reason="from_drug_use" section="S1" start="10377" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Pancreatitis" meddra_llt_id="10033645" meddra_pt="Pancreatitis" meddra_pt_id="10033645" />
    </Mention>
    <Mention id="M148" len="8" reason="from_drug_use" section="S1" start="10391" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Vomiting" meddra_llt_id="10047700" meddra_pt="Vomiting" meddra_pt_id="10047700" />
    </Mention>
    <Mention id="M27" len="23" reason="general_term" section="S1" start="10403" type="NonOSE_AE">
      <Normalization meddra_llt="Hepatobiliary disease" meddra_llt_id="10062000" meddra_pt="Hepatobiliary disease" meddra_pt_id="10062000" />
    </Mention>
    <Mention id="M149" len="21" reason="from_drug_use" section="S1" start="10437" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Cholestatic hepatitis" meddra_llt_id="10008639" meddra_pt="Hepatitis cholestatic" meddra_pt_id="10019754" />
    </Mention>
    <Mention id="M150" len="27" reason="from_drug_use" section="S1" start="10460" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Hepatocellular injury" meddra_llt_id="10019837" meddra_pt="Hepatocellular injury" meddra_pt_id="10019837" />
    </Mention>
    <Mention id="M151" len="26" reason="from_drug_use" section="S1" start="10493" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Mixed liver injury" meddra_llt_id="10066758" meddra_pt="Mixed liver injury" meddra_pt_id="10066758" />
    </Mention>
    <Mention id="M4" len="13" reason="preexisting_condition_or_risk_factor" section="S1" start="10759" type="Not_AE_Candidate">
      <Normalization meddra_llt="Chronic liver disease" meddra_llt_id="10008953" meddra_pt="Liver disorder" meddra_pt_id="10024670" />
      <Normalization meddra_pt="Hepatotoxicity" meddra_pt_id="10019851" />
    </Mention>
    <Mention id="M5" len="9" reason="preexisting_condition_or_risk_factor" section="S1" start="10811" type="Not_AE_Candidate">
      <Normalization meddra_llt="Hepatitis" meddra_llt_id="10019717" meddra_pt="Hepatitis" meddra_pt_id="10019717" />
    </Mention>
    <Mention id="M28" len="38" reason="general_term" section="S1" start="10824" type="NonOSE_AE">
      <Normalization meddra_llt="Other disorders of skin and subcutaneous tissue" meddra_llt_id="10032001" meddra_pt="Skin disorder" meddra_pt_id="10040831" />
    </Mention>
    <Mention id="M152" len="10" reason="from_drug_use" section="S1" start="10864" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Angioedema" meddra_llt_id="10002424" meddra_pt="Angioedema" meddra_pt_id="10002424" />
    </Mention>
    <Mention id="M153" len="8" reason="from_drug_use" section="S1" start="10876" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Bruising" meddra_llt_id="10006504" meddra_pt="Contusion" meddra_pt_id="10050584" />
    </Mention>
    <Mention id="M154" len="19" reason="from_drug_use" section="S1" start="10886" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Erythema multiforme" meddra_llt_id="10015218" meddra_pt="Erythema multiforme" meddra_pt_id="10015218" />
    </Mention>
    <Mention id="M155" len="16" reason="from_drug_use" section="S1" start="10907" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Erythema nodosum" meddra_llt_id="10015226" meddra_pt="Erythema nodosum" meddra_pt_id="10015226" />
    </Mention>
    <Mention id="M156" len="8" reason="from_drug_use" section="S1" start="10925" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Pruritus" meddra_llt_id="10037087" meddra_pt="Pruritus" meddra_pt_id="10037087" />
    </Mention>
    <Mention id="M157" len="24" reason="from_drug_use" section="S1" start="10935" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Syndrome Stevens-Johnson" meddra_llt_id="10042849" meddra_pt="Stevens-Johnson syndrome" meddra_pt_id="10042033" />
    </Mention>
    <Mention id="M158" len="26" reason="from_drug_use" section="S1" start="10960" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Toxic epidermal necrolysis" meddra_llt_id="10044223" meddra_pt="Toxic epidermal necrolysis" meddra_pt_id="10044223" />
    </Mention>
    <Mention id="M159" len="9" reason="from_drug_use" section="S1" start="10988" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Urticaria" meddra_llt_id="10046735" meddra_pt="Urticaria" meddra_pt_id="10046735" />
    </Mention>
    <Mention id="M29" len="47" reason="general_term" section="S1" start="11001" type="NonOSE_AE">
      <Normalization meddra_llt="Musculoskeletal disorder" meddra_llt_id="10048592" meddra_pt="Musculoskeletal disorder" meddra_pt_id="10048592" />
    </Mention>
    <Mention id="M160" len="10" reason="from_drug_use" section="S1" start="11050" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Arthralgia" meddra_llt_id="10003239" meddra_pt="Arthralgia" meddra_pt_id="10003239" />
    </Mention>
    <Mention id="M161" len="7" reason="from_drug_use" section="S1" start="11062" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Myalgia" meddra_llt_id="10028411" meddra_pt="Myalgia" meddra_pt_id="10028411" />
    </Mention>
    <Mention id="M162" len="13" reason="from_drug_use" section="S1" start="11080" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Cramp muscle" meddra_llt_id="10011291" meddra_pt="Muscle spasms" meddra_pt_id="10028334" />
    </Mention>
    <Mention id="M30" len="27" reason="general_term" section="S1" start="11097" type="NonOSE_AE">
      <Normalization meddra_llt="Disorder renal" meddra_llt_id="10013263" meddra_pt="Renal disorder" meddra_pt_id="10038428" />
    </Mention>
    <Mention id="M163" len="8" reason="from_drug_use" section="S1" start="11126" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Enuresis" meddra_llt_id="10014928" meddra_pt="Enuresis" meddra_pt_id="10014928" />
    </Mention>
    <Mention id="M31" len="52" reason="general_term" section="S1" start="11150" type="NonOSE_AE">
      <Normalization meddra_llt="General symptom" meddra_llt_id="10060891" meddra_pt="General symptom" meddra_pt_id="10060891" />
    </Mention>
    <Mention id="M164" len="5" reason="from_drug_use" section="S1" start="11204" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Edema" meddra_llt_id="10014210" meddra_pt="Oedema" meddra_pt_id="10030095" />
    </Mention>
    <Mention id="M6" len="6" reason="indication" section="S1" start="11227" type="Not_AE_Candidate">
      <Normalization meddra_llt="Asthma" meddra_llt_id="10003553" meddra_pt="Asthma" meddra_pt_id="10003553" />
    </Mention>
    <Mention id="M174" len="21" reason="from_drug_use" section="S1" start="11277" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Eosinophilia" meddra_llt_id="10014950" meddra_pt="Eosinophilia" meddra_pt_id="10014950" />
    </Mention>
    <Mention id="M175" len="10" reason="from_drug_use" section="S1" start="11347" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Vasculitis" meddra_llt_id="10047115" meddra_pt="Vasculitis" meddra_pt_id="10047115" />
    </Mention>
    <Mention id="M176" len="22" reason="from_drug_use" section="S1" start="11374" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Churg Strauss syndrome" meddra_llt_id="10009164" meddra_pt="Eosinophilic granulomatosis with polyangiitis" meddra_pt_id="10078117" />
    </Mention>
    <Mention id="M32" len="12" reason="manifestation_or_complication" section="S1" start="11596" type="NonOSE_AE">
      <Normalization meddra_llt="Eosinophilia" meddra_llt_id="10014950" meddra_pt="Eosinophilia" meddra_pt_id="10014950" />
    </Mention>
    <Mention id="M33" len="15" reason="manifestation_or_complication" section="S1" start="11610" type="NonOSE_AE">
      <Normalization meddra_llt="Vasculitic rash" meddra_llt_id="10047111" meddra_pt="Vasculitic rash" meddra_pt_id="10047111" />
    </Mention>
    <Mention id="M34" len="28" reason="manifestation_or_complication" section="S1" start="11627" type="NonOSE_AE">
      <Normalization meddra_llt="Disorder lung" meddra_llt_id="10013235" meddra_pt="Lung disorder" meddra_pt_id="10025082" />
    </Mention>
    <Mention id="M35" len="21" reason="manifestation_or_complication" section="S1" start="11657" type="NonOSE_AE">
      <Normalization meddra_llt="Cardiac disorder" meddra_llt_id="10061024" meddra_pt="Cardiac disorder" meddra_pt_id="10061024" />
    </Mention>
    <Mention id="M36" len="10" reason="manifestation_or_complication" section="S1" start="11687" type="NonOSE_AE">
      <Normalization meddra_llt="Neuropathy" meddra_llt_id="10029328" meddra_pt="Neuropathy peripheral" meddra_pt_id="10029331" />
    </Mention>
    <Mention id="M177" len="12" reason="preexisting_condition_or_risk_factor" section="S2" start="1188" type="Not_AE_Candidate">
      <Normalization meddra_llt="Bronchospasm" meddra_llt_id="10006482" meddra_pt="Bronchospasm" meddra_pt_id="10006482" />
    </Mention>
    <Mention id="M178" len="20" reason="preexisting_condition_or_risk_factor" section="S2" start="1204" type="Not_AE_Candidate">
      <Normalization meddra_llt="Asthma" meddra_llt_id="10003553" meddra_pt="Asthma" meddra_pt_id="10003553" />
    </Mention>
    <Mention id="M179" len="18" reason="preexisting_condition_or_risk_factor" section="S2" start="1236" type="Not_AE_Candidate">
      <Normalization meddra_llt="Status asthmaticus" meddra_llt_id="10041961" meddra_pt="Status asthmaticus" meddra_pt_id="10041961" />
    </Mention>
    <Mention id="M180" len="29" reason="preexisting_condition_or_risk_factor" section="S2" start="1379" type="Not_AE_Candidate">
      <Normalization meddra_llt="Exacerbation of asthma" meddra_llt_id="10015575" meddra_pt="Asthma" meddra_pt_id="10003553" />
    </Mention>
    <Mention id="M181" len="38" reason="preexisting_condition_or_risk_factor" section="S2" start="1428" type="Not_AE_Candidate">
      <Normalization meddra_llt="Asthma exercise induced" meddra_llt_id="10003557" meddra_pt="Asthma exercise induced" meddra_pt_id="10003557" />
    </Mention>
    <Mention id="M185" len="19" reason="preexisting_condition_or_risk_factor" section="S2" start="1807" type="Not_AE_Candidate">
      <Normalization meddra_llt="Aspirin asthma" meddra_llt_id="10003533" meddra_pt="Aspirin-exacerbated respiratory disease" meddra_pt_id="10075084" />
    </Mention>
    <Mention id="M182" len="10" reason="preexisting_condition_or_risk_factor" section="S2" start="1994" type="Not_AE_Candidate">
      <Normalization meddra_llt="Asthmatic" meddra_llt_id="10003565" meddra_pt="Asthma" meddra_pt_id="10003553" />
    </Mention>
    <Mention id="M186" len="19" reason="preexisting_condition_or_risk_factor" section="S2" start="2021" type="Not_AE_Candidate">
      <Normalization meddra_llt="Aspirin asthma" meddra_llt_id="10003533" meddra_pt="Aspirin-exacerbated respiratory disease" meddra_pt_id="10075084" />
    </Mention>
    <Mention id="M189" len="38" reason="preexisting_condition_or_risk_factor" section="S2" start="2076" type="Not_AE_Candidate">
      <Normalization meddra_llt="Aspirin asthma" meddra_llt_id="10003533" meddra_pt="Aspirin-exacerbated respiratory disease" meddra_pt_id="10075084" />
    </Mention>
    <Mention id="M187" len="17" reason="preexisting_condition_or_risk_factor" section="S2" start="2166" type="Not_AE_Candidate">
      <Normalization meddra_llt="Aspirin-sensitive asthma" meddra_llt_id="10003534" meddra_pt="Aspirin-exacerbated respiratory disease" meddra_pt_id="10075084" />
    </Mention>
    <Mention id="M188" len="9" reason="preexisting_condition_or_risk_factor" section="S2" start="2184" type="Not_AE_Candidate">
      <Normalization meddra_llt="Asthmatic" meddra_llt_id="10003565" meddra_pt="Asthma" meddra_pt_id="10003553" />
    </Mention>
    <Mention id="M214" len="23" reason="from_drug_use" section="S2" start="2276" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Neuropsychiatric symptoms" meddra_llt_id="10078497" meddra_pt="Neuropsychiatric symptoms" meddra_pt_id="10078497" />
    </Mention>
    <Mention id="M196" len="9" reason="from_drug_use" section="S2" start="2432" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Agitation" meddra_llt_id="10001497" meddra_pt="Agitation" meddra_pt_id="10001497" />
    </Mention>
    <Mention id="M197" len="19" reason="from_drug_use" section="S2" start="2443" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Aggressive behavior" meddra_llt_id="10062375" meddra_pt="Aggression" meddra_pt_id="10001488" />
    </Mention>
    <Mention id="M198" len="9" reason="from_drug_use" section="S2" start="2466" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Hostility" meddra_llt_id="10020400" meddra_pt="Hostility" meddra_pt_id="10020400" />
    </Mention>
    <Mention id="M199" len="11" reason="from_drug_use" section="S2" start="2477" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Feeling anxious" meddra_llt_id="10016323" meddra_pt="Anxiety" meddra_pt_id="10002855" />
    </Mention>
    <Mention id="M200" len="10" reason="from_drug_use" section="S2" start="2490" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Anxiety/depression" meddra_llt_id="10002872" meddra_pt="Depression" meddra_pt_id="10012378" />
    </Mention>
    <Mention id="M201" len="14" reason="from_drug_use" section="S2" start="2502" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Disorientation" meddra_llt_id="10013395" meddra_pt="Disorientation" meddra_pt_id="10013395" />
    </Mention>
    <Mention id="M202" len="24" reason="from_drug_use" section="S2" start="2518" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Disturbance in attention" meddra_llt_id="10013496" meddra_pt="Disturbance in attention" meddra_pt_id="10013496" />
    </Mention>
    <Mention id="M203" len="19" reason="from_drug_use" section="S2" start="2544" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Dream delirium" meddra_llt_id="10013628" meddra_pt="Abnormal dreams" meddra_pt_id="10000125" />
    </Mention>
    <Mention id="M204" len="14" reason="from_drug_use" section="S2" start="2565" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Hallucinations" meddra_llt_id="10019077" meddra_pt="Hallucination" meddra_pt_id="10019063" />
    </Mention>
    <Mention id="M205" len="8" reason="from_drug_use" section="S2" start="2581" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Insomnia" meddra_llt_id="10022437" meddra_pt="Insomnia" meddra_pt_id="10022437" />
    </Mention>
    <Mention id="M206" len="12" reason="from_drug_use" section="S2" start="2591" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Irritability" meddra_llt_id="10022998" meddra_pt="Irritability" meddra_pt_id="10022998" />
    </Mention>
    <Mention id="M207" len="17" reason="from_drug_use" section="S2" start="2605" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Memory impairment" meddra_llt_id="10027175" meddra_pt="Memory impairment" meddra_pt_id="10027175" />
    </Mention>
    <Mention id="M208" len="12" reason="from_drug_use" section="S2" start="2624" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Restlessness" meddra_llt_id="10038743" meddra_pt="Restlessness" meddra_pt_id="10038743" />
    </Mention>
    <Mention id="M209" len="12" reason="from_drug_use" section="S2" start="2638" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Somnambulism" meddra_llt_id="10041347" meddra_pt="Somnambulism" meddra_pt_id="10041347" />
    </Mention>
    <Mention id="M210" len="17,8" reason="from_drug_use" section="S2" start="2652,2674" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Suicidal behavior" meddra_llt_id="10065607" meddra_pt="Suicidal behaviour" meddra_pt_id="10065604" />
    </Mention>
    <Mention id="M215" len="17" reason="from_drug_use" section="S2" start="2652" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Suicidal ideation" meddra_llt_id="10042458" meddra_pt="Suicidal ideation" meddra_pt_id="10042458" />
    </Mention>
    <Mention id="M211" len="7" reason="from_drug_use" section="S2" start="2694" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Suicide" meddra_llt_id="10042462" meddra_pt="Completed suicide" meddra_pt_id="10010144" />
    </Mention>
    <Mention id="M212" len="3" reason="from_drug_use" section="S2" start="2704" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Tic" meddra_llt_id="10043833" meddra_pt="Tic" meddra_pt_id="10043833" />
    </Mention>
    <Mention id="M213" len="6" reason="from_drug_use" section="S2" start="2713" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Tremor" meddra_llt_id="10044565" meddra_pt="Tremor" meddra_pt_id="10044565" />
    </Mention>
    <Mention id="M190" len="23" reason="AE_only_as_instruction" section="S2" start="2888" type="NonOSE_AE">
      <Normalization meddra_llt="Neuropsychiatric symptoms" meddra_llt_id="10078497" meddra_pt="Neuropsychiatric symptoms" meddra_pt_id="10078497" />
    </Mention>
    <Mention id="M183" len="6" reason="indication" section="S2" start="3201" type="Not_AE_Candidate">
      <Normalization meddra_llt="Asthma" meddra_llt_id="10003553" meddra_pt="Asthma" meddra_pt_id="10003553" />
    </Mention>
    <Mention id="M216" len="21" reason="from_drug_use" section="S2" start="3251" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Eosinophilia" meddra_llt_id="10014950" meddra_pt="Eosinophilia" meddra_pt_id="10014950" />
    </Mention>
    <Mention id="M217" len="10" reason="from_drug_use" section="S2" start="3321" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Vasculitis" meddra_llt_id="10047115" meddra_pt="Vasculitis" meddra_pt_id="10047115" />
    </Mention>
    <Mention id="M218" len="22" reason="from_drug_use" section="S2" start="3348" type="OSE_Labeled_AE">
      <Normalization meddra_llt="Churg Strauss syndrome" meddra_llt_id="10009164" meddra_pt="Eosinophilic granulomatosis with polyangiitis" meddra_pt_id="10078117" />
    </Mention>
    <Mention id="M191" len="12" reason="manifestation_or_complication" section="S2" start="3570" type="NonOSE_AE">
      <Normalization meddra_llt="Eosinophilia" meddra_llt_id="10014950" meddra_pt="Eosinophilia" meddra_pt_id="10014950" />
    </Mention>
    <Mention id="M192" len="15" reason="manifestation_or_complication" section="S2" start="3584" type="NonOSE_AE">
      <Normalization meddra_llt="Vasculitic rash" meddra_llt_id="10047111" meddra_pt="Vasculitic rash" meddra_pt_id="10047111" />
    </Mention>
    <Mention id="M193" len="28" reason="manifestation_or_complication" section="S2" start="3601" type="NonOSE_AE">
      <Normalization meddra_llt="Disorder lung" meddra_llt_id="10013235" meddra_pt="Lung disorder" meddra_pt_id="10025082" />
    </Mention>
    <Mention id="M194" len="21" reason="manifestation_or_complication" section="S2" start="3631" type="NonOSE_AE">
      <Normalization meddra_llt="Cardiac disorder" meddra_llt_id="10061024" meddra_pt="Cardiac disorder" meddra_pt_id="10061024" />
    </Mention>
    <Mention id="M195" len="10" reason="manifestation_or_complication" section="S2" start="3661" type="NonOSE_AE">
      <Normalization meddra_llt="Neuropathy" meddra_llt_id="10029328" meddra_pt="Neuropathy peripheral" meddra_pt_id="10029331" />
    </Mention>
    <Mention id="M184" len="15" reason="preexisting_condition_or_risk_factor" section="S2" start="3862" type="Not_AE_Candidate">
      <Normalization meddra_llt="Phenylketonuria" meddra_llt_id="10034872" meddra_pt="Phenylketonuria" meddra_pt_id="10034872" />
    </Mention>
  </Mentions>
</GoldLabel>